KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Change in Working Capital Change in Working Capital Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Teva Pharmaceutical Industries (TEVA) Shares Issued (2016)

Teva Pharmaceutical Industries filings provide 8 years of Shares Issued readings, the most recent being $1.0 million for Q4 2016.

On a quarterly basis, Shares Issued fell 99.97% to $1.0 million in Q4 2016 year-over-year; TTM through Sep 2017 was $1.0 million, a 99.97% decrease, with the full-year FY2016 number at $35.0 million, down 98.94% from a year prior.
Shares Issued hit $1.0 million in Q4 2016 for Teva Pharmaceutical Industries, down from $14.0 million in the prior quarter.
In the past five years, Shares Issued ranged from a high of $3.0 billion in Q4 2015 to a low of -$10.0 million in Q4 2012.
Median Shares Issued over the past 5 years was $15.0 million (2013), compared with a mean of $197.2 million.
Biggest five-year swings in Shares Issued: tumbled 162.5% in 2012 and later surged 4800.0% in 2014.
Teva Pharmaceutical Industries' Shares Issued stood at -$10.0 million in 2012, then soared by 720.0% to $62.0 million in 2013, then surged by 261.29% to $224.0 million in 2014, then skyrocketed by 1217.86% to $3.0 billion in 2015, then plummeted by 99.97% to $1.0 million in 2016.
The last three reported values for Shares Issued were $1.0 million (Q4 2016), $14.0 million (Q3 2016), and $7.0 million (Q2 2016) per Business Quant data.